Aligos Therapeutics Inc (ALGS)
19.46
+0.01
(+0.05%)
USD |
NASDAQ |
Nov 14, 16:00
19.79
+0.33
(+1.70%)
After-Hours: 17:02
Aligos Therapeutics Market Cap: 69.82M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 69.78M |
| November 12, 2024 | 64.04M |
| November 11, 2024 | 50.19M |
| November 08, 2024 | 36.56M |
| November 07, 2024 | 35.59M |
| November 06, 2024 | 33.55M |
| November 05, 2024 | 35.27M |
| November 04, 2024 | 34.01M |
| November 01, 2024 | 31.75M |
| October 31, 2024 | 32.52M |
| October 30, 2024 | 32.48M |
| October 29, 2024 | 31.12M |
| October 28, 2024 | 29.49M |
| October 25, 2024 | 27.93M |
| October 24, 2024 | 30.02M |
| October 23, 2024 | 23.97M |
| October 22, 2024 | 24.40M |
| October 21, 2024 | 24.24M |
| October 18, 2024 | 24.10M |
| October 17, 2024 | 23.97M |
| October 16, 2024 | 24.54M |
| October 15, 2024 | 24.17M |
| October 14, 2024 | 24.04M |
| October 11, 2024 | 25.34M |
| October 10, 2024 | 22.91M |
| Date | Value |
|---|---|
| October 09, 2024 | 25.80M |
| October 08, 2024 | 24.34M |
| October 07, 2024 | 24.94M |
| October 04, 2024 | 27.13M |
| October 03, 2024 | 27.23M |
| October 02, 2024 | 28.56M |
| October 01, 2024 | 28.66M |
| September 30, 2024 | 28.79M |
| September 27, 2024 | 25.70M |
| September 26, 2024 | 25.63M |
| September 25, 2024 | 26.27M |
| September 24, 2024 | 26.05M |
| September 23, 2024 | 25.89M |
| September 20, 2024 | 29.21M |
| September 19, 2024 | 32.54M |
| September 18, 2024 | 45.26M |
| September 17, 2024 | 45.99M |
| September 16, 2024 | 45.45M |
| September 13, 2024 | 47.30M |
| September 12, 2024 | 44.84M |
| September 11, 2024 | 44.11M |
| September 10, 2024 | 44.07M |
| September 09, 2024 | 62.10M |
| September 06, 2024 | 39.98M |
| September 05, 2024 | 38.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
22.91M
Minimum
Oct 10 2024
1.282B
Maximum
Jun 11 2021
276.48M
Average
58.65M
Median
Aug 23 2022
Market Cap Benchmarks
| Haemonetics Corp | 4.561B |
| Pliant Therapeutics Inc | 781.97M |
| CEL-SCI Corp | 34.44M |
| AIM ImmunoTech Inc | 16.59M |
| IGC Pharma Inc | 26.62M |
Market Cap Related Metrics
| PS Ratio | 17.68 |
| Price to Book Value | 1.394 |
| Price | 19.46 |
| Earnings Yield | -87.90% |